Skip to main navigation Skip to search Skip to main content

PI3K Signalling and Aberrant Neutrophil Function in COPD; Implications for Disease Susceptibility, Prognosis and Therapeutic Targeting

Project Details

Short titlePI3K Signalling and Aberrant Neutrophil Function in COPD; Implications for Disease Susceptibility, Prognosis and Therapeutic Targeting
StatusFinished
Effective start/end date1/11/14 → 15/01/18

Funding

  • Medical Research Council
  • WEST MIDLANDS CHEST FUND
  • GlaxoSmithKline (United Kingdom)